Reduction of lymphocyte count at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study.

Fei, Jun; Fu, Lin; Li, Ying; Xiang, Hui-Xian; Xiang, Ying; Li, Meng-Die; Liu, Fang-Fang; Xu, De-Xiang; Zhao, Hui

Fei, Jun; Fu, Lin; Li, Ying; Xiang, Hui-Xian; Xiang, Ying; Li, Meng-Die; Liu, Fang-Fang; Xu, De-Xiang; Zhao, Hui.

Afiliación

Fei J; Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, China.
Fu L; Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, China.
Li Y; Department of Toxicology, Anhui Medical University, Hefei, Anhui Province, China.
Xiang HX; Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Xiang Y; Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, China.
Li MD; Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, China.
Liu FF; Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, China.
Xu DX; Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, China.
Zhao H; Department of Toxicology, Anhui Medical University, Hefei, Anhui Province, China.

Arch Med Sci ; 19(5): 1303-1313, 2023.

Article en En | MEDLINE | ID: mdl-37732034

Palabras clave

coronavirus disease 2019; death risk; multiple organ injuries; severe acute respiratory syndrome coronavirus-2; severity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 4_covid_19 Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Arch Med Sci Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google